BMA recommends access to cross sex hormones for 16 and 17-year-olds, indicating increased support for gender incongruence treatment.
recommends that 16 and 17 year olds get access to cross sex hormones Adele WatersUnder 18s with gender incongruence or dysphoria should have NHS access to cross sex hormones, the BMA says.Currently, new NHS prescriptions for these drugs are not permitted for this age group, but they are available through private prescription.
No takes yet. Share an insight, caveat, or question.
Adele Waters (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: